DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,401 filers reported holding DANAHER CORPORATION in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $102,302,303 | -20.2% | 409,474 | -20.3% | 0.62% | -24.4% |
Q1 2024 | $128,236,718 | -11.8% | 513,522 | -18.3% | 0.82% | -18.2% |
Q4 2023 | $145,360,735 | +7.4% | 628,314 | +2.1% | 1.00% | +4.6% |
Q3 2023 | $135,356,535 | -27.9% | 615,393 | -21.3% | 0.96% | -29.3% |
Q2 2023 | $187,689,120 | -13.8% | 782,038 | -16.7% | 1.36% | -10.2% |
Q1 2023 | $217,762,873 | -13.1% | 938,690 | -0.6% | 1.51% | -10.7% |
Q4 2022 | $250,641,085 | +9.5% | 944,363 | +6.6% | 1.69% | +4.8% |
Q3 2022 | $228,924,000 | +1.6% | 886,262 | -0.3% | 1.61% | -13.0% |
Q2 2022 | $225,328,000 | -8.6% | 888,842 | +5.8% | 1.86% | +10.6% |
Q1 2022 | $246,401,000 | -17.1% | 840,051 | -7.0% | 1.68% | -11.6% |
Q4 2021 | $297,054,000 | +21.3% | 902,873 | +12.3% | 1.90% | +13.9% |
Q3 2021 | $244,834,000 | +5.9% | 804,246 | -6.6% | 1.66% | +5.2% |
Q2 2021 | $231,097,000 | +36.3% | 861,147 | +8.4% | 1.58% | +12.1% |
Q1 2021 | $169,536,000 | -3.9% | 794,526 | -0.0% | 1.41% | +1.0% |
Q4 2020 | $176,504,000 | +7.4% | 794,530 | +4.1% | 1.40% | -9.5% |
Q3 2020 | $164,277,000 | +56.3% | 762,942 | +28.4% | 1.54% | +39.1% |
Q2 2020 | $105,092,000 | +123.0% | 594,284 | +89.2% | 1.11% | +112.5% |
Q1 2020 | $47,134,000 | -2.2% | 314,164 | +0.0% | 0.52% | +1.0% |
Q4 2019 | $48,208,000 | +153.5% | 314,097 | +138.5% | 0.52% | +105.2% |
Q3 2019 | $19,020,000 | -28.2% | 131,691 | -29.2% | 0.25% | -23.6% |
Q2 2019 | $26,480,000 | +13.9% | 186,098 | +5.7% | 0.33% | +11.1% |
Q1 2019 | $23,242,000 | -46.0% | 176,044 | -57.8% | 0.30% | -55.1% |
Q4 2018 | $43,032,000 | -7.3% | 417,314 | -2.3% | 0.66% | +7.1% |
Q3 2018 | $46,433,000 | +246.9% | 427,319 | +215.1% | 0.62% | +191.0% |
Q2 2018 | $13,384,000 | +143.5% | 135,629 | +141.6% | 0.21% | +125.5% |
Q1 2018 | $5,497,000 | +11.1% | 56,143 | +5.3% | 0.09% | +9.3% |
Q4 2017 | $4,950,000 | -51.6% | 53,334 | -55.3% | 0.09% | -52.0% |
Q3 2017 | $10,227,000 | +100.6% | 119,220 | +97.4% | 0.18% | +86.5% |
Q2 2017 | $5,097,000 | +4.3% | 60,397 | +5.7% | 0.10% | +1.1% |
Q1 2017 | $4,886,000 | +37.2% | 57,118 | +24.9% | 0.10% | +15.9% |
Q4 2016 | $3,560,000 | -42.9% | 45,743 | -42.5% | 0.08% | -45.3% |
Q3 2016 | $6,240,000 | -69.2% | 79,604 | -60.3% | 0.15% | -71.5% |
Q2 2016 | $20,247,000 | -1.0% | 200,461 | -7.5% | 0.53% | +2.9% |
Q1 2016 | $20,444,000 | +42.9% | 216,690 | +40.7% | 0.51% | +33.4% |
Q4 2015 | $14,309,000 | +392.1% | 154,055 | +351.4% | 0.38% | +439.4% |
Q3 2015 | $2,908,000 | -5.7% | 34,129 | -5.3% | 0.07% | +10.9% |
Q2 2015 | $3,083,000 | -73.9% | 36,023 | -74.1% | 0.06% | -73.1% |
Q1 2015 | $11,829,000 | +291.9% | 139,292 | +295.6% | 0.24% | +277.8% |
Q4 2014 | $3,018,000 | – | 35,206 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |